Celyad Oncology S.A [CYAD] vs BEL 20 [^BFX] Detailed Stock Comparison
Index Comparison
You are comparing market indices. Financial metrics such as P/E ratios, dividend yields, and financial statements are not available for indices as they represent market benchmarks rather than individual companies.
Available data includes: price performance, historical charts, and basic market statistics.
Celyad Oncology S.A. vs BEL 20 Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Celyad Oncology S.A. | -2.07% | -3.33% | -6.45% | -21.62% | 52.63% | 61.11% |
| BEL 20 | -0.98% | 4.20% | -2.79% | 2.03% | 6.05% | 2.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Celyad Oncology S.A. | -34.09% | -44.23% | -93.65% | -99.43% | -98.56% | -98.56% |
| BEL 20 | 27.43% | 37.02% | 32.34% | 55.53% | 91.62% | 33.15% |